Given current price action the market is not anticipating a meaningful increase in revenue. The conditions are ripe for a breakout to the upside should the market be surprised by strong 4Q results.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025